TAMMY COVINGTON: Open Payments
NPI 1831599893 · CLERMONT, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,646 in 99 payments from 13 companies in 2025. Trend: 2023 $1,399 · 2024 $1,922 · 2025 $1,646
Food & beverage: $1,614Education: $32
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 36 | $534 |
| PFIZER INC. | 15 | $285 |
| Gilead Sciences, Inc. | 3 | $158 |
| Phathom Pharmaceuticals, Inc. | 23 | $124 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $105 |
| Lilly USA, LLC | 4 | $92 |
| GENZYME CORPORATION | 4 | $90 |
| Aimmune Therapeutics, Inc. | 3 | $83 |
| Novo Nordisk Inc | 3 | $74 |
| Madrigal Pharmaceuticals | 1 | $32 |
Products named: RINVOQ, SKYRIZI, VELSIPITY, XELJANZ, Livdelzi, VOQUEZNA, ENTYVIO, DUPIXENT.
Industry payments across FL — which companies pay providers there.
